
GC19116
Danirixin
Also known as 1-[4-chloro-2-hydroxy-3-[(3S)-piperidin-3-yl]sulfonylphenyl]-3-(3-fluoro-2-methylphenyl)urea
Danirixin is a selective, and reversible CXCR2 antagonist, with IC50 of 12·5 nM for CXCL8
ChemicalCAS954126-98-8MW441.9FormulaC19H21ClFN3O4S
- CAS number
- 954126-98-8
- Molecular weight
- 441.9
- Formula
- C19H21ClFN3O4S
- Solubility
- DMSO : 8 mg/mL (18·10 mM)
- InChIKey
- NGYNBSHYFOFVLS-LBPRGKRZSA-N
- Catalogue number
- GC19116
- Brand
- GLPBIO
Computed properties PubChem CID 24780598 · XLogP 3.1 · TPSA 116 Ų · H-bond donors 4
- XLogP
- 3.1
- TPSA
- 116 Ų
- H-bond donors
- 4
- H-bond acceptors
- 6
- Rotatable bonds
- 4
- Heavy atoms
- 29
SMILES CC1=C(C=CC=C1F)NC(=O)NC2=C(C(=C(C=C2)Cl)S(=O)(=O)[C@H]3CCCNC3)O
Computed descriptors from PubChem (CID 24780598), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il